Class I · Recall · initiated June 26, 2026 · Ongoing
Total Nutrition's second moringa recall in five weeks: TNVitamins 100% Organic Moringa
Five weeks after recalling a moringa greens capsule, the Farmingdale, New York firm recalled TNVitamins 100% Organic Moringa capsules and powder for Salmonella contamination.
The record
- Firm
- Total Nutrition Inc, Deer Park, NY
- Product
- 1. TNVitamins 100% Organic Moringa Capsules 1,200 mg 2. TNVitamins 100% Organic Moringa Powder 96 grams
- Reason, as filed
- “Contaminated with Salmonella”
- Classification
- Class I (Class I: reasonable probability of serious health consequences or death)
- Recall number
- H-1185-2026
- Initiated
- June 26, 2026
- Posted by FDA
- July 29, 2026
- Status
- Ongoing · Voluntary: Firm initiated
- Quantity
- 8492 total units
- Distribution
- nationwide
Verify: search any recall number above in FDA's enforcement report database.
Why it happened, in plain English
The filed reason is flat: contaminated with Salmonella. This is the firm’s second moringa recall of the summer, covering both a capsule and a loose powder from the same botanical. Two products, one ingredient, two recalls five weeks apart is the signature of a contaminated ingredient source that was not caught on receipt, rather than a single processing slip.
The record does not name the supplier. Between May and August 2026 at least seven firms recalled moringa or greens powders for Salmonella, including one bulk supplier whose lot went to four manufacturers.
Who else should care
Anyone buying moringa from the same broker or importer channels. If you cannot say which farm-level lot your moringa came from, you are exposed to the same event every one of these firms was.
Check: your supplier qualification file for moringa. Does it include a validated kill step at the supplier (steam, irradiation, or equivalent), or only a certificate?
This firm's record
Second Class I Salmonella recall at Total Nutrition in 2026 (the first was May 22). The firm also received an FDA warning letter in July 2018.
Related actions
Written 2026-09-08. Analysis is editorial; the record above is FDA's.